Erudio Healtherudio.com
Sponsor
Shanghai Henlius Biotech trials: what clinicians said in public
No HCP commentary report on a trial sponsored by Shanghai Henlius Biotech yet. Erudio has found public clinician commentary on 4 clinical trials sponsored by Shanghai Henlius Biotech: ASTRIDE, ASTRUM-002, ASTRUM-005 and NCT06115642. Each trial's page lists the podcasts, videos and posts found so far and the price of a report.
Listed by lead sponsor as registered on ClinicalTrials.gov (Shanghai Henlius Biotech). A trial led by a partner or a research group is on that sponsor's page. Only trials with public clinician commentary found are listed, not every trial the sponsor runs.
| Trial | Indication | Phase | Statements | Sources | Size | Checked | Preview |
|---|---|---|---|---|---|---|---|
| No report yetTrials with public commentary we haven't built a report for. Size is an estimate of the verified statements the commentary we've indexed so far will yield; final coverage is set when we build the report, within 24 hours of your confirmed order. You never pay more than quoted: a report delivered at a smaller size costs that size's price. Some can also be requested as a free preview. | |||||||
| ASTRUM-005 NCT04063163 · Shanghai Henlius Biotech DeepView → | previously untreated extensive-stage small cell lung cancer | Phase 3 | Deep | View | |||
| ASTRIDE NCT05468489 · Shanghai Henlius Biotech DeepView → | previously untreated extensive-stage small cell lung cancer | Phase 2 | Deep | View | |||
| ASTRUM-002 NCT03952403 · Shanghai Henlius Biotech FocusedView → | first-line advanced non-squamous non-small cell lung cancer | Phase 3 | Focused | View | |||
| NCT06115642 NCT06115642 · Shanghai Henlius Biotech FocusedView → | advanced/metastatic malignant solid tumors | Phase 1 | Focused | View | |||